The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care

Kaohsiung Medical University

Status

Completed

Conditions

Chronic Kidney Disease

Hypertension

Treatments

Device: iCKD APP

Study type

Interventional

Funder types

Other

Identifiers

NCT03649516

KMUHIRB-F(II)-20180055

Details and patient eligibility

About

Apply Mobile APP Intervention ( iCKD APP) to current chronic kidney disease care program.
Conduct a randomized clinical trial to evaluate the clinical effectiveness of this mobile device on health behavior improvement in chronic kidney disease patients.

Full description

A mHealth app (iCKD APP) was designed to assist CKD patients to monitor their home bio-information data. Patients will be randomly assigned into the iCKD APP group(intervention) and traditional care group (control). Participants will be randomized into an 1:1 manner (intervention : control). Random assignment occurred after the consent and initial enrollment interview. Individuals randomized to the iCKD APP will provide with the equipment after randomization. Participants will follow for at least 6 months before the exit interview.

Enrollment

101 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects are 20 years old and above, Chinese speaking, and able and willing to provide informed consent.
Subjects own mobile devices such as cell phones and tablets.
Subjects were diagnosed with Chronic Kidney Diseases and were taking a single antihypertensive agent for more than three months or they are not receiving treatment but with systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.

Exclusion criteria